## Abstract Allelic loss on chromosome 13 occurs frequently in esophageal squamous cell carcinoma. However, studies of the two known tumor suppressor genes located on 13q, __RB1__ and __BRCA2__, have shown few mutations, suggesting that other genes are likely to be involved in the development of th
Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors
β Scribed by Aritoshi Iida; Yusuke Nakamura; Takashi Imai; Kirsten Blake; Terry Tunny; Shelley Klemm; Michael Stowasser; Richard Gordon; Nicholas Hayward
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 516 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
We examined loss of heterozygosity (LOH) in I 4 aldosterone-producing adrenal tumors, with six linearly ordered restriction fragment length polymorphism (RFLP) markers that map within a 12-cM region containing the MEN/ locus on I I q 13. Among I I tumors that were informative for at least one marker, five showed LOH at one or more loci, and two distinct regions of deletion were identified. The proximal region overlapped with the location of the MEN/ locus previously predicted by linkage analyses in MENl families and the commonly deleted region in hyperparathyroid tumors. This suggests that one of the genes associated with development of aldosterone-producing adrenal tumors may coincide with the MEN/ locus, and that a second Rene, distal to the MEN/ locus, may also play a role in the development of this type of tumor. Genes Chrornosorn Cancer -. I
12:73-75 (199.5).
π SIMILAR VOLUMES
## Abstract HΓΌrthle thyroid tumors are characterized by frequent numerical chromosomal aberrations, including aneuploidy or polyploidy, losses and gains of some chromosomal regions and DNA fragmentation. In recent years, great attention has been paid to the combined analysis of morphologic and gene
An extended analysis for loss of heterozygosity (LOH) on eight chromosomes was conducted in a series of 82 Wilms tumors. Observed rates of allele loss were: 9.5% (1p), 5% (4q), 6% (6p), 3% (7p), 9.8% (11q), 28% (11p15), 13.4% (16q), 8.8% (18p), and 13.8% (22q). Known regions of frequent allele loss
Multiple endocrine neoplasia type 1 syndrome (MEN1, MIM 131100), an autosomal dominant disease, is characterized by parathyroid hyperplasia, pancreatic endocrine tumors, and pituitary adenomas. These tumors also occur sporadically. Both the familial (MEN1) and the sporadic tumors reveal loss of hete
Breast-carcinoma development presumably results from multiple mutational events in tumor-associated genes. Certain results indicate that some tumor-suppressor genes may combine their pathogenetic potential to synergistically promote tumor growth. In an effort to identify such mechanisms in breast tu
Tumor and constitutional chromosome arm I I p genotypes were compared in 6 hepatoblastoma (HB) patients and 2 adrenal adenoma (AA) patients, with one HB patient and both AA patients displaying clinical features associated with the Beckwith-Wiedemann syndrome (BWS). Using up t o 14 chromosome I I pol